- Home
- MNTX vs CDTX Comparison
MNTX vs CDTX Comparison
Compare MNTX & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTX
- CDTX
- Stock Information
- Founded
- MNTX 1993
- CDTX 2012
- Country
- MNTX United States
- CDTX United States
- Employees
- MNTX N/A
- CDTX N/A
- Industry
- MNTX Industrial Machinery/Components
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNTX Technology
- CDTX Health Care
- Exchange
- MNTX Nasdaq
- CDTX Nasdaq
- Market Cap
- MNTX 77.7M
- CDTX 79.3M
- IPO Year
- MNTX 2005
- CDTX 2015
- Fundamental
- Price
- MNTX $5.72
- CDTX $14.72
- Analyst Decision
- MNTX Hold
- CDTX Strong Buy
- Analyst Count
- MNTX 1
- CDTX 5
- Target Price
- MNTX $5.80
- CDTX $30.50
- AVG Volume (30 Days)
- MNTX 118.8K
- CDTX 21.1K
- Earning Date
- MNTX 11-07-2024
- CDTX 11-07-2024
- Dividend Yield
- MNTX N/A
- CDTX N/A
- EPS Growth
- MNTX 248.43
- CDTX N/A
- EPS
- MNTX 0.46
- CDTX N/A
- Revenue
- MNTX $294,775,000.00
- CDTX $41,152,000.00
- Revenue This Year
- MNTX $6.97
- CDTX N/A
- Revenue Next Year
- MNTX $12.08
- CDTX N/A
- P/E Ratio
- MNTX $12.56
- CDTX N/A
- Revenue Growth
- MNTX 1.10
- CDTX 19.60
- 52 Week Low
- MNTX $3.07
- CDTX $10.00
- 52 Week High
- MNTX $9.16
- CDTX $24.40
- Technical
- Relative Strength Index (RSI)
- MNTX 61.84
- CDTX 70.77
- Support Level
- MNTX $5.65
- CDTX $12.89
- Resistance Level
- MNTX $5.71
- CDTX $13.78
- Average True Range (ATR)
- MNTX 0.03
- CDTX 0.70
- MACD
- MNTX -0.02
- CDTX 0.09
- Stochastic Oscillator
- MNTX 53.85
- CDTX 99.24
About MNTX Manitex International Inc.
Manitex International Inc through its subsidiaries is engaged in the design, manufacture, and distribution of engineered lifting solutions. Its products include boom trucks, truck cranes, and sign cranes. The company's segments include Lifting Equipment and Rental Equipment. It generates maximum revenue from the Lifting Equipment segment. Geographically, it derives majority of its revenue from the United States.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.